PNNL evaluates bacterial, fungi, and algae strains as part of a four-step process to streamline and standardize biomanufacturing processing.

PNNL partners with the Department of Homeland Security, industry, and the first-responder community to improve the effectiveness and safety during biodetection responses.

Pacific Northwest National Laboratory’s (PNNL) Generative AI (GenAI) investment aims to harness this transformative technology to drive innovation across the science, energy, and security research domains.

PNNL is heavily engaged in the development and use of mass spectrometry technology across its science, energy, and security missions, from fundamental research through mature operational capabilities.

Pacific Northwest National Laboratory supports innovations in data analytics, instrumentation, and experimental techniques for the Northwest (NW) Biopreparedness Research Virtual Environment (BRaVE) Initiative.

The Pacific Northwest Advanced Compound Identification Center (PNACIC) brings together innovations in integrated chemistry and advanced instrumentation to create a platform for comprehensive, unambiguous identification of metabolites.

The Pacific Northwest Center for Cryo-EM electron microscopy is a user facility operated jointly by PNNL and Oregon Health & Science University.

Using a reverse genome strategy to target the molecular basis of function.

Advancing our understanding of how soil microbial communities respond to—and affect—changing environmental conditions